首页> 外文期刊>American pharmaceutical review >Sterility testing of difficult-to-filter and growth-inhibiting samples.
【24h】

Sterility testing of difficult-to-filter and growth-inhibiting samples.

机译:无菌测试难以过滤和生长抑制样品。

获取原文
获取原文并翻译 | 示例
           

摘要

An important question for many companies in the pharmaceutical industry is whether to use membrane filtration or direct inoculation of liquid culture when developing new sterility testing methods. USP <71> recommends membrane filtration as the preferred method for sterility applications whenever the nature of the product permits. Filtration methods have the advantage of allowing large sample volumes to be tested for meeting USP requirements and recommendations. Also, for products with antimicrobial activity, filtration allows rinsing and thus the removal of the inhibitory characteristics of the product. While membrane filtration is often straightforward, some sample types can be challenging. These include difficult-to-filter viscous oils, water-in-oil emulsions and fatty base ointments as well as samples containing substances that inhibit microbial growth. High-density cell cultures can also prove problematic. However, membrane filtration can be made to work for most such products perfectly well.
机译:在制药行业的许多公司的一个重要问题是在开发新的无菌测试方法时是否使用膜过滤或直接接种液体培养。 USP <71>在产品允许的性质时,建议在产品许可的性质时作为无菌应用的优选方法。过滤方法具有允许进行大量样品卷以满足USP要求和建议的优点。此外,对于具有抗微生物活性的产品,过滤允许漂洗,从而去除产品的抑制特性。虽然膜过滤通常是直接的,但一些样品类型可能是具有挑战性的。这些包括难以过滤的粘性油,油内乳液和脂肪碱液,以及含有抑制微生物生长的物质的样品。高密度细胞培养物也可以证明问题。然而,可以使膜过滤适用于大多数此类产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号